Peptide Therapeutics Market to Witness 5.94% CAGR by 2031 | SkyQuest Technology |
Globe Newswire |
09/27 |
08:00 |
SEALSQ Research Receives Recognition at CRYPTOLOGY2024 for Post-Quantum Work |
Globe Newswire |
09/27 |
08:00 |
Hurco Celebrates Successful IMTS as Show Generates Excitement Over Technological Advancements |
Globe Newswire |
09/27 |
08:00 |
Lexicon to Present Phase 3 Trial Design for Sotagliflozin in Hypertrophic Cardiomyopathy (HCM) at Upcoming Medical Congress |
Globe Newswire |
09/27 |
08:00 |
Empire State Development Announces Round Seven Winners of Luminate NY Accelerator Competition |
Globe Newswire |
09/27 |
08:00 |
WeightWatchers Announces Executive Leadership Transition |
Globe Newswire |
09/27 |
08:00 |
Refurbished Laboratory Equipment Market Estimated to Reach USD 37.6 billion, Advancing at a CAGR of 5.1% by 2031: Analysis by Transparency Market Research, Inc. |
Globe Newswire |
09/27 |
07:56 |
Beyond Air Provides LungFit® PH System to U.S. Naval Hospital Guam for Neonatal Critical Care in Partnership with TrillaMed |
Globe Newswire |
09/27 |
07:34 |
Beyond Air Announces Termination of the Loan and Security Agreements with Avenue Capital |
Globe Newswire |
09/27 |
07:32 |
Beyond Air Announces $20.6 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules |
Globe Newswire |
09/27 |
07:30 |
Polymeric Membrane Market Projected to Reach USD 11,153.9 Million by 2033, Driven by Rising Demand for Clean Water and Water Treatment Applications | Future Market Insights, Inc. |
Globe Newswire |
09/27 |
07:30 |
Venus Concept Announces $15 million Debt-to-Equity Exchange Transaction |
Globe Newswire |
09/27 |
07:30 |
Jeffs’ Brands: Fort Products Was Selected by Amazon UK as Key Account, and Now Eligible for the Top Seller Program |
Globe Newswire |
09/27 |
07:23 |
G2 Names INE 2024 Enterprise and Small Business Leader |
Globe Newswire |
09/27 |
07:22 |
Welshare Health Introduces AI-Driven App to Inaugurate the Future of Patient-Driven Medical Research |
Globe Newswire |
09/27 |
07:09 |
Dupixent® (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients with Chronic Obstructive Pulmonary Disease (COPD) |
Globe Newswire |
09/27 |
07:00 |
Press Release: Dupixent approved in China as the first-ever biologic medicine for patients with COPD |
Globe Newswire |
09/27 |
07:00 |
Jianzhi Education Technology Group Company Limited Reports Half Year 2024 Financial Results |
Globe Newswire |
09/27 |
07:00 |
Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes |
Globe Newswire |
09/27 |
06:57 |
US Army Bowl National Combine Returns for 3rd Annual Event Powered by Signing Day Sports |
Globe Newswire |
09/27 |
06:30 |
InitVerse Shines at InnoBlock2024 with Major Announcements |
Globe Newswire |
09/27 |
06:24 |
Trump favors huge new tariffs. What are they, and how do they work? |
AP Online |
09/27 |
06:12 |
Brewing a cold beer on a warming planet is hard. Germany uses education to fight climate change |
AP Online |
09/27 |
05:53 |
VEON Bonds to Re-Enter CEMBI and JACI Indices |
Globe Newswire |
09/27 |
01:30 |
OKX Wallet Launches 'Solana Account Recycling,' Enabling Users to Easily Reclaim Unused SOL |
Globe Newswire |
09/27 |
01:01 |